clarithromycin has been researched along with Cross Infection in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Abdrabou, AMM; Berger, FK; Bischoff, M; Gärtner, BC; Margardt, L; Mellmann, A; von Müller, L | 1 |
| Kim, H; Matsui, M; Mori, S; Mukai, M; Rimbara, E; Shibayama, K; Suzuki, S; Takahashi, S; Yamamoto, S | 1 |
| Aberrane, S; Frija-Masson, J; Housset, B; Jabot, L; Mangiapan, G; Monnet, I | 1 |
| Antony, SJ | 1 |
| Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
| Callen, EC; Kessler, TL | 1 |
| Brochot, P; Desplaces, N; Direz, G; Eschard, JP; Salmon, JH; Ziza, JM | 1 |
| Blanc, C; Gillet, M; Halkic, N; Kovacsovics, T; Ksontini, R; Meylan, P; Mosimann, F; Muheim, C; Scholl, B | 1 |
| Bonmarin, I; Deutsch, P; Floret, D; Gaudelus, J; Grimprel, E; Guérin, N; Guiso, N; Morer, I | 1 |
| Carpentier, M; Delmée, M; Glupczynski, Y; Gordts, B; Magerman, K; Simon, A; Surmont, I; Van de Vyvere, M; Van Landuyt, H; Van Nimmen, L; Van Noyen, R | 1 |
| Engelhardt, E; Feldmann, R; Salomon, D; Skaria, A | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Huth, RG; Jahn, B; Kamin, W; Knuf, M; Meyer, HG; Trübel, HK | 1 |
1 review(s) available for clarithromycin and Cross Infection
| Article | Year |
|---|---|
[Action to be taken when facing one or more cases of whooping-cough].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Cross Infection; Drug Combinations; Enzyme-Linked Immunosorbent Assay; France; Humans; Pertussis Vaccine; Polymerase Chain Reaction; Whooping Cough | 2005 |
13 other study(ies) available for clarithromycin and Cross Infection
| Article | Year |
|---|---|
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests | 2007 |
Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
Topics: Anti-Bacterial Agents; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Rifampin; Sentinel Surveillance | 2022 |
Helicobacter cinaedi and Helicobacter fennelliae transmission in a hospital from 2008 to 2012.
Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cluster Analysis; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Helicobacter; Helicobacter Infections; Hospitals; Humans; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing | 2013 |
[Non-tuberculous mycobacterial infection of a totally implanted perfusion device].
Topics: Administration, Oral; Anti-Bacterial Agents; Antineoplastic Agents; Catheter-Related Infections; Clarithromycin; Cross Infection; Female; Humans; Infusions, Intravenous; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 2015 |
Catheter related line sepsis resulting from Mycobacterium chelonae infection in an immunocompromised host.
Topics: Adult; Catheter-Related Infections; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ovarian Neoplasms; Sepsis; Vascular Access Devices | 2015 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Mycobacterium fortuitum infections associated with laparoscopic gastric banding.
Topics: Adult; Clarithromycin; Cross Infection; Device Removal; Drug Therapy, Combination; Female; Gastroplasty; Humans; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Obesity, Morbid; Postoperative Complications; Prosthesis-Related Infections; Young Adult | 2011 |
Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Cross Infection; Discitis; Disease Outbreaks; Diskectomy, Percutaneous; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Sacroiliitis; Surgical Wound Infection; Treatment Outcome | 2012 |
Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiviral Agents; Bone and Bones; Clarithromycin; Cross Infection; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Legionnaires' Disease; Leishmaniasis, Visceral; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Schistosomicides; Viral Load | 2004 |
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefotaxime; Cefuroxime; Child; Child, Preschool; Clarithromycin; Clavulanic Acids; Cross Infection; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Middle Aged | 1996 |
[Postoperative infection with Mycobacterium chelonae].
Topics: Aged; Clarithromycin; Combined Modality Therapy; Coronary Artery Bypass; Cross Infection; Humans; Infrared Rays; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Saphenous Vein; Surgical Wound Infection | 1996 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Male; Nutrition Disorders; Pneumonia, Bacterial | 2002 |